Skip to search formSkip to main contentSkip to account menu

autologous tumor cell vaccine

Known as: AC vaccine, ATCV, Autologous Cell Vaccine 
A therapeutic agent produced by isolating tumor cells from an individual and processing these tumor cells into a vaccine formulation in vitro; the… 
National Institutes of Health

Related topics

Related topics

2 relations
NCIt Antineoplastic Agent Terminologyautologous tumor cell vaccine/CD40-ligand/interleukin-2 gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma
A xenogeneic melanoma-antigen-enhanced allogeneic tumor cell vaccine (ATCV) is an appealing strategy for anti-cancer… 
Highly Cited
2005
Highly Cited
2005
Clinical trials of antitumor vaccination with an autologous tumor cell vaccine modified by virus infection: improvement of patient survival based on improved antitumor immune memory
For active specific immunotherapy of cancer patients, we designed the autologous virus–modified tumor cell vaccine ATV-NDV. The… 
Highly Cited
2005
Highly Cited
2005
Responses to Human CD40 Ligand/Human Interleukin-2 Autologous Cell Vaccine in Patients with B-Cell Chronic Lymphocytic Leukemia
Purpose: Human CD40 ligand activates the malignant B-cell chronic lymphocytic leukemia cells and enhances their capacity to… 
2005
2005
Isolation and characterization of a new type of chlorovirus that infects an endosymbiotic Chlorella strain of the heliozoon Acanthocystis turfacea.
A novel virus, named Acanthocystis turfacea Chlorella virus (ATCV), that infects endosymbiotic Chlorella algae of the heliozoon… 
Highly Cited
2003
Highly Cited
2003
Application of autologous tumor cell vaccine and NDV vaccine in treatment of tumors of digestive tract.
AIM To treat patients with stage I-IV malignant tumors of digestive tract using autologous tumor cell vaccine and NDV (Newcastle… 
Highly Cited
2002
Highly Cited
2002
Irradiated cells from autologous tumor cell lines as patient-specific vaccine therapy in 125 patients with metastatic cancer: induction of delayed-type hypersensitivity to autologous tumor is…
OBJECTIVE We established short-term cultures of pure tumor cells for use as autologous tumor cell vaccines in an effort to study… 
Highly Cited
1995
Highly Cited
1995
Establishment of micrometastatic carcinoma cell lines: a novel source of tumor cell vaccines.
BACKGROUND Cancer cells of microscopic metastases can be envisaged as ideal constituents for the development of a genetically… 
Highly Cited
1993
Highly Cited
1993
Establishing In Vitro Cultures of Autologous Tumor Cells for Use in Active Specific Immunotherapy
Summary For active specific immunotherapy, autologous tumor cells grown in vitro may be a more appropriate source of tumor… 
Highly Cited
1991
Highly Cited
1991
Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases.
Twenty-four patients with metastatic melanoma were treated with a novel form of active immunotherapy, autologous tumor cell… 
Highly Cited
1988
Highly Cited
1988
Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria and tetanus in infants.
Clinical and serological responses of infants to primary immunization with diphtheria-tetanus-pertussis (DTP) vaccine containing… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)